• The Bulgarian Drug Agency issued a new marketing authorization for the medicinal product Linezolid-Tchaikapharma

    November 7, 2016

    The newest medicinal product placed on the market after having received a marketing authorization from the Bulgarian Drug Agency by the Ministry of Health is the infusion solution Linezolid-Tchaikapharma 2 mg/ml.
    Its active substance is linezolid, and a packaging contents 300 ml x 5 pcs. or 10 pcs.
    This medicinal product is used in cases of hospital- or community-acquired pneumonias, where they are known or suspected to be caused by sensitive Gram-positive bacteria.
    Linezolid-Tchaikapharma is subject to medical prescription.

    ATC code: J01XX 08